Skip to main content
. 2019 Aug 13;18(4):2759–2776. doi: 10.3892/etm.2019.7886

Figure 2.

Figure 2.

Main signaling pathways modulated by KP in various diseases. HCC, hepatocellular carcinoma; VEGF, vascular endothelial growth factor; IVD, intervertebral disc; UC, ulcerative colitis; ALI, acute lung injury; GC, gastric cancer; CCA, cholangiocarcinoma; MAPK, mitogen-activated protein kinase; RA, rheumatoid arthritis; DOX, doxorubicin; KP, kaempferol.